Published in Adv Virus Res on January 01, 2007
The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta (2011) 1.64
Advances in human B19 erythrovirus biology. J Virol (2010) 1.10
Multiple pathways involved in porcine parvovirus cellular entry and trafficking toward the nucleus. J Virol (2010) 1.04
Structural studies of adeno-associated virus serotype 8 capsid transitions associated with endosomal trafficking. J Virol (2011) 1.04
Depletion of virion-associated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3'-to-5' direction from an otherwise intact viral particle. J Virol (2009) 1.03
Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species. J Virol (2010) 1.02
Virus strategies for passing the nuclear envelope barrier. Nucleus (2012) 0.98
Densovirus infectious pathway requires clathrin-mediated endocytosis followed by trafficking to the nucleus. J Virol (2009) 0.97
Isolation and Genomic Characterization of a Duck-Origin GPV-Related Parvovirus from Cherry Valley Ducklings in China. PLoS One (2015) 0.95
Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer. J Virol (2014) 0.95
Mutations at the base of the icosahedral five-fold cylinders of minute virus of mice induce 3'-to-5' genome uncoating and critically impair entry functions. J Virol (2011) 0.95
Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae. Virology (2011) 0.95
Mechanical elasticity as a physical signature of conformational dynamics in a virus particle. Proc Natl Acad Sci U S A (2012) 0.91
Nuclear envelope disruption involving host caspases plays a role in the parvovirus replication cycle. J Virol (2011) 0.91
Recruitment of DNA replication and damage response proteins to viral replication centers during infection with NS2 mutants of Minute Virus of Mice (MVM). Virology (2010) 0.91
Structure of a packaging-defective mutant of minute virus of mice indicates that the genome is packaged via a pore at a 5-fold axis. J Virol (2011) 0.89
Evolution of eukaryotic single-stranded DNA viruses of the Bidnaviridae family from genes of four other groups of widely different viruses. Sci Rep (2014) 0.88
Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication. PLoS Negl Trop Dis (2010) 0.87
A novel group of diverse Polinton-like viruses discovered by metagenome analysis. BMC Biol (2015) 0.87
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses. Mol Ther Methods Clin Dev (2016) 0.86
Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid. J Virol (2012) 0.86
Structural basis of glycan interaction in gastroenteric viral pathogens. Curr Opin Virol (2014) 0.85
Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses. Virology (2013) 0.85
Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts. Virology (2013) 0.84
Viral oncolysis that targets Raf-1 signaling control of nuclear transport. J Virol (2009) 0.83
CpG dinucleotide frequencies reveal the role of host methylation capabilities in parvovirus evolution. J Virol (2013) 0.83
Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data. Hum Gene Ther (2015) 0.83
Nuclear entry of DNA viruses. Front Microbiol (2015) 0.82
Simple tests for rapid detection of canine parvovirus antigen and canine parvovirus-specific antibodies. Clin Vaccine Immunol (2008) 0.82
An in-frame deletion in the NS protein-coding sequence of parvovirus H-1PV efficiently stimulates export and infectivity of progeny virions. J Virol (2012) 0.82
Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression. PLoS One (2012) 0.81
Characterization of the early steps of human parvovirus B19 infection. J Virol (2012) 0.81
Densovirus crosses the insect midgut by transcytosis and disturbs the epithelial barrier function. J Virol (2013) 0.80
Structural characterization of H-1 parvovirus: comparison of infectious virions to empty capsids. J Virol (2013) 0.80
Autonomous parvoviruses neither stimulate nor are inhibited by the type I interferon response in human normal or cancer cells. J Virol (2014) 0.79
Electron microscopy analysis of a disaccharide analog complex reveals receptor interactions of adeno-associated virus. J Struct Biol (2013) 0.79
LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells. J Virol (2012) 0.77
Generation of an adenovirus-parvovirus chimera with enhanced oncolytic potential. J Virol (2012) 0.77
Four amino acids of an insect densovirus capsid determine midgut tropism and virulence. J Virol (2012) 0.77
Efficient recombinant parvovirus production with the help of adenovirus-derived systems. J Vis Exp (2012) 0.77
Glycated AAV vectors: chemical redirection of viral tissue tropism. Bioconjug Chem (2011) 0.76
Molecular epidemiology of seal parvovirus, 1988-2014. PLoS One (2014) 0.75
A comparison of mouse parvovirus 1 infection in BALB/c and C57BL/6 mice: susceptibility, replication, shedding, and seroconversion. Comp Med (2015) 0.75
Oncolytic parvoviruses: from basic virology to clinical applications. Virol J (2015) 0.75
The family Parvoviridae. Arch Virol (2013) 2.12
Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc Natl Acad Sci U S A (2005) 1.85
Seroepidemiology of human bocavirus defined using recombinant virus-like particles. J Infect Dis (2008) 1.80
Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system. J Virol (2002) 1.43
VP2 cleavage and the leucine ring at the base of the fivefold cylinder control pH-dependent externalization of both the VP1 N terminus and the genome of minute virus of mice. J Virol (2006) 1.41
Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential. J Virol (2005) 1.34
A conserved leucine that constricts the pore through the capsid fivefold cylinder plays a central role in parvoviral infection. Virology (2004) 1.29
Functional glycomic analysis of human milk glycans reveals the presence of virus receptors and embryonic stem cell biomarkers. J Biol Chem (2012) 1.07
Parvovirus diversity and DNA damage responses. Cold Spring Harb Perspect Biol (2013) 1.04
Depletion of virion-associated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3'-to-5' direction from an otherwise intact viral particle. J Virol (2009) 1.03
Genome packaging sense is controlled by the efficiency of the nick site in the right-end replication origin of parvoviruses minute virus of mice and LuIII. J Virol (2005) 1.01
Encapsidation of minute virus of mice DNA: aspects of the translocation mechanism revealed by the structure of partially packaged genomes. Virology (2005) 1.00
Host range mutants of Minute Virus of Mice with a single VP2 amino acid change require additional silent mutations that regulate NS2 accumulation. Virology (2005) 0.96
Mutations at the base of the icosahedral five-fold cylinders of minute virus of mice induce 3'-to-5' genome uncoating and critically impair entry functions. J Virol (2011) 0.95
Replication initiator protein NS1 of the parvovirus minute virus of mice binds to modular divergent sites distributed throughout duplex viral DNA. J Virol (2007) 0.93
Resolution of parvovirus dimer junctions proceeds through a novel heterocruciform intermediate. J Virol (2003) 0.92
Recruitment of DNA replication and damage response proteins to viral replication centers during infection with NS2 mutants of Minute Virus of Mice (MVM). Virology (2010) 0.91
Differential roles for the C-terminal hexapeptide domains of NS2 splice variants during MVM infection of murine cells. Virology (2006) 0.91
Parvoviral left-end hairpin ears are essential during infection for establishing a functional intranuclear transcription template and for efficient progeny genome encapsidation. J Virol (2013) 0.91
Structure of a packaging-defective mutant of minute virus of mice indicates that the genome is packaged via a pore at a 5-fold axis. J Virol (2011) 0.89
Segregation of a single outboard left-end origin is essential for the viability of parvovirus minute virus of mice. J Virol (2006) 0.85
Reverse genetic system for the analysis of parvovirus telomeres reveals interactions between transcription factor binding sites in the hairpin stem. J Virol (2003) 0.85
Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses. Virology (2013) 0.85
A nonproliferating parvovirus vaccine vector elicits sustained, protective humoral immunity following a single intravenous or intranasal inoculation. J Virol (2004) 0.84
Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts. Virology (2013) 0.84
Evolution to pathogenicity of the parvovirus minute virus of mice in immunodeficient mice involves genetic heterogeneity at the capsid domain that determines tropism. J Virol (2007) 0.82
The parvoviral capsid controls an intracellular phase of infection essential for efficient killing of stepwise-transformed human fibroblasts. Virology (2011) 0.80
Maintenance of the flip sequence orientation of the ears in the parvoviral left-end hairpin is a nonessential consequence of the critical asymmetry in the hairpin stem. J Virol (2012) 0.79
Exploring the contribution of distal P4 promoter elements to the oncoselectivity of Minute Virus of Mice. Virology (2006) 0.79
Toll-like receptor 9 in plasmacytoid dendritic cells fails to detect parvoviruses. J Virol (2013) 0.78